Treace Medical Concepts Files 8-K

TL;DR

Treace Medical Concepts filed an 8-K on May 21, 2025, for shareholder votes and financial docs.

AI Summary

On May 21, 2025, Treace Medical Concepts, Inc. filed an 8-K report. The filing primarily concerns the submission of matters to a vote of security holders and includes financial statements and exhibits. No specific financial figures or voting outcomes were detailed in the provided excerpt.

Why It Matters

This filing indicates Treace Medical Concepts is engaging in corporate actions requiring shareholder input and is providing necessary financial documentation.

Risk Assessment

Risk Level: low — The filing is procedural and does not contain information that inherently increases or decreases risk.

Key Players & Entities

• TREACE MEDICAL CONCEPTS, INC. (company) — Registrant
• May 21, 2025 (date) — Date of earliest event reported

FAQ

From the Filing

0000950170-25-075805.txt : 20250521 0000950170-25-075805.hdr.sgml : 20250521 20250521163009 ACCESSION NUMBER: 0000950170-25-075805 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 10 CONFORMED PERIOD OF REPORT: 20250521 ITEM INFORMATION: Submission of Matters to a Vote of Security Holders ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20250521 DATE AS OF CHANGE: 20250521 FILER: COMPANY DATA: COMPANY CONFORMED NAME: TREACE MEDICAL CONCEPTS, INC. CENTRAL INDEX KEY: 0001630627 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] ORGANIZATION NAME: 08 Industrial Applications and Services EIN: 471052611 STATE OF INCORPORATION: FL FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-40355 FILM NUMBER: 25973534 BUSINESS ADDRESS: STREET 1: 100 PALMETTO PARK PLACE CITY: PONTE VEDRA STATE: FL ZIP: 32081 BUSINESS PHONE: (904) 373-5940 MAIL ADDRESS: STREET 1: 100 PALMETTO PARK PLACE CITY: PONTE VEDRA STATE: FL ZIP: 32081 8-K 1 tmci-20250521.htm 8-K 8-K false 0001630627 0001630627 2025-05-21 2025-05-21   UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 21, 2025 TREACE MEDICAL CONCEPTS, Inc. (Exact name of registrant as specified in its charter)           Delaware 001-40355 47-1052611 (State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Identification Number)   100 Palmetto Park Place Ponte Vedra , Florida 32081 (Address of principal executive offices, including Zip Code) Registrant’s telephone number, including area code: ( 904 ) 373-5940 Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act:           Title of each class Trading Symbol(s) Name of each exchange on which registered Common Stock, $0.001 par value per share TMCI The Nasdaq Global Select Market Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐     Item 5.07. Submission of Matters to a Vote of Security Holders. At the 2025 Annual Meeting of Stockholders (the "Meeting") of Treace Medical Concepts, Inc. (the "Company") held on May 20, 2025, the stockholders of the Company voted on the following proposals, each of which is described in the Company’s Definitive Proxy Statement on Schedule 14A filed with the Securities and Exchange Commission on April 7, 2025. The results of voting on the three proposals, including final voting tabulations, are set forth below. Proposal 1: Election of Directors. The stockholders elected, by the votes indicated below, the following nominees to the Company’s Board of Directors to serve as Class I directors for a three-year term of office expiring at the 2028 annual meeting of stockholders or until their respec